Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating growth factors

Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating growth factors

Abstract Background Rituximab‐based combinations are the standard of care in diffuse large B‐cell lymphoma (DLBCL) and follicular lymphoma (FL). Despite being on market for over 20 years, some of the adverse effects associated with the use of rituximab are not well known. Drug‐induced interstitial p...

Celý popis

Podrobná bibliografie
Hlavní autoři: Elina Kaprio, Roosa Prusila, Susanna Tokola, Milla E. L. Kuusisto, Esa Jantunen, Hanne Kuitunen, Taina Turpeenniemi‐Hujanen, Outi Kuittinen
Médium: Článek
Jazyk:English
Vydáno: Wiley 2024-01-01
Edice:Cancer Medicine
Témata:
diffuse large B‐cell lymphoma
drug‐induced pneumonitis
follicular lymphoma
granulocyte colony‐stimulating factors
On-line přístup:https://doi.org/10.1002/cam4.6898

Internet

https://doi.org/10.1002/cam4.6898

Podobné jednotky